| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.008 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.01 |